CNS Pharmaceuticals, Inc. (CNSP)

NASDAQ: CNSP · Real-Time Price · USD

5.94

+0.11 (1.89%)

Aug 24, 2026, 4:00 PM EDT - Market closed

CNS Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.99	7.2	6.46	0.55	10.06	5
Cash & Short-Term Investments	19.99	7.2	6.46	0.55	10.06	5
Cash Growth	64.76%	11.45%	1077.53%	-94.54%	100.93%	-64.35%
Other Receivables	-	-	0.88	-	-	-
Receivables	-	-	0.88	-	-	-
Prepaid Expenses	1.87	0.86	1.29	0.84	2.51	2.47
Other Current Assets	0.07	0.05	0.02	0.2	-	-
Total Current Assets	21.92	8.1	8.66	1.59	12.56	7.48
Property, Plant & Equipment	0.02	0.02	0.01	0	0.01	0.02
Long-Term Deferred Charges	-	-	-	-	-	0.33
Other Long-Term Assets	-	0.5	0.04	0.1	0.48	0.93
Total Assets	21.94	8.62	8.7	1.7	13.05	8.76

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.74	3.77	2.2	5.83	4.51	1.98
Accrued Expenses	-	-	-	-	-	0.22
Short-Term Debt	-	0.33	0.33	0.3	0.41	0.39
Total Current Liabilities	3.74	4.1	2.52	6.13	4.92	2.59
Total Liabilities	3.74	4.1	2.52	6.13	4.92	2.59

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	126	104.8	90.6	65.13	58.85	41.6
Retained Earnings	-107.8	-100.28	-84.42	-69.57	-50.72	-35.44
Shareholders' Equity	18.2	4.52	6.18	-4.43	8.13	6.16
Total Liabilities & Equity	21.94	8.62	8.7	1.7	13.05	8.76

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	0.33	0.33	0.3	0.41	0.39
Net Cash (Debt)	19.99	6.87	6.14	0.25	9.65	4.62
Net Cash Growth	66.43%	12.02%	2374.76%	-97.43%	108.92%	-66.05%
Net Cash Per Share	9.16	15.50	192.79	-	-	-
Filing Date Shares Outstanding	1.46	0.81	0.25	-	-	-
Total Common Shares Outstanding	1.46	0.63	0.12	-	-	-
Working Capital	18.19	4	6.13	-4.54	7.64	4.88
Book Value Per Share	12.45	7.15	52.43	-	-	-
Tangible Book Value	18.2	4.52	6.18	-4.43	8.13	6.16
Tangible Book Value Per Share	12.45	7.15	52.43	-	-	-

SEC Filings: 10-K · 10-Q